(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AMGEN

ST13

US500000078736482

Class

5

Filing

78736482

Registration

3921146

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

73

Latest update

01/30/2026

Trademark type

Word

Nice classes

5

Filing date

10/19/2005

Registration date

02/15/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/25/2021

Last transaction

01/30/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

1984-04-00

First use in commerce

1984-04-00

Drawing code

4

Owner type

03

Owner location

Thousand Oaks, CA

Examiner

FAIRBANKS, RONALD L

Law office

M80

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Amgen Inc.

Representatives

Elsa D. Lemoine Amgen Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

House mark for a full line of pharmaceuticals; pharmaceutical preparationspharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorderscomplications associated therewith; pharmaceuticals for stimulating the growth of platelets and platelet precursor cells; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of bone disease; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith

Publications

History of USPTO decisions and trademark events.

73 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/25/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/25/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/25/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/25/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/25/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/29/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/29/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/29/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/29/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/29/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/29/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/25/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/25/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/25/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/25/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

12/14/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/15/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/07/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/07/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/02/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/02/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/29/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/29/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/29/2017

E815

TEAS SECTION 8 & 15 RECEIVED

01/30/2017

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/15/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

02/15/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/11/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

01/10/2011

ALIE

ASSIGNED TO LIE

01/10/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/15/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/13/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/12/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/12/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/13/2010

GNRT

NON-FINAL ACTION E-MAILED

05/13/2010

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/13/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/10/2009

GNRT

NON-FINAL ACTION E-MAILED

12/10/2009

CNRT

SU - NON-FINAL ACTION - WRITTEN

12/10/2009

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/19/2009

IUAF

USE AMENDMENT FILED

11/06/2009

EISU

TEAS STATEMENT OF USE RECEIVED

11/06/2009

EX5G

SOU EXTENSION 5 GRANTED

04/23/2009

EXT5

SOU EXTENSION 5 FILED

04/21/2009

EEXT

SOU TEAS EXTENSION RECEIVED

04/21/2009

EX4G

SOU EXTENSION 4 GRANTED

11/06/2008

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/06/2008

EXT4

SOU EXTENSION 4 FILED

11/05/2008

EEXT

SOU TEAS EXTENSION RECEIVED

11/05/2008

EX3G

SOU EXTENSION 3 GRANTED

04/23/2008

EXT3

SOU EXTENSION 3 FILED

04/16/2008

EEXT

SOU TEAS EXTENSION RECEIVED

04/16/2008

EX2G

SOU EXTENSION 2 GRANTED

11/09/2007

EXT2

SOU EXTENSION 2 FILED

10/25/2007

EEXT

SOU TEAS EXTENSION RECEIVED

10/25/2007

EX1G

SOU EXTENSION 1 GRANTED

08/06/2007

EXT1

SOU EXTENSION 1 FILED

05/01/2007

EEXT

SOU TEAS EXTENSION RECEIVED

05/01/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

11/07/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/26/2006

PUBO

PUBLISHED FOR OPPOSITION

08/15/2006

NPUB

NOTICE OF PUBLICATION

07/26/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/09/2006

ALIE

ASSIGNED TO LIE

05/31/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/24/2006

XAEC

EXAMINER'S AMENDMENT ENTERED

05/23/2006

GNEA

EXAMINERS AMENDMENT E-MAILED

05/23/2006

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/23/2006

GNRT

NON-FINAL ACTION E-MAILED

05/01/2006

CNRT

NON-FINAL ACTION WRITTEN

05/01/2006

DOCK

ASSIGNED TO EXAMINER

04/23/2006

NWAP

NEW APPLICATION ENTERED

10/25/2005

Continuous trademark protection

Get notified about every new filing that threatens AMGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.